Literature DB >> 25643734

Persistence of a single clone of Streptococcus agalactiae causing disease in tilapia (Oreochromis sp.) cultured in Colombia over 8 years.

P Barato1, E R Martins2, J Melo-Cristino2, C A Iregui1, M Ramirez2.   

Abstract

Entities:  

Keywords:  Colombia; Streptococcus agalactiae; molecular epidemiology; tilapia

Mesh：

Year:  2015        PMID： 25643734     DOI： 10.1111/jfd.12337

Source DB:  PubMed          Journal:  J Fish Dis        ISSN： 0140-7775            Impact factor:   2.767


× No keyword cloud information.
  3 in total

1.  One hypervirulent clone, sequence type 283, accounts for a large proportion of invasive Streptococcus agalactiae isolated from humans and diseased tilapia in Southeast Asia.

Authors:  Timothy Barkham; Ruth N Zadoks; Mohammad Noor Amal Azmai; Stephen Baker; Vu Thi Ngoc Bich; Victoria Chalker; Man Ling Chau; David Dance; Rama Narayana Deepak; H Rogier van Doorn; Ramona A Gutierrez; Mark A Holmes; Lan Nguyen Phu Huong; Tse Hsien Koh; Elisabete Martins; Kurosh Mehershahi; Paul Newton; Lee Ching Ng; Nguyen Ngoc Phuoc; Ornuma Sangwichian; Pongpun Sawatwong; Uraiwan Surin; Thean Yen Tan; Wen Ying Tang; Nguyen Vu Thuy; Paul Turner; Manivanh Vongsouvath; Defeng Zhang; Toni Whistler; Swaine L Chen
Journal:  PLoS Negl Trop Dis       Date:  2019-06-27

2.  Transcriptome and Proteome of Fish-Pathogenic Streptococcus agalactiae Are Modulated by Temperature.

Authors:  Guilherme C Tavares; Alex F Carvalho; Felipe L Pereira; Cristiana P Rezende; Vasco A C Azevedo; Carlos A G Leal; Henrique C P Figueiredo
Journal:  Front Microbiol       Date:  2018-11-02       Impact factor: 5.640

3.  Establishment and characterization of a competitive exclusion bacterial culture derived from Nile tilapia (Oreochromis niloticus) gut microbiomes showing antibacterial activity against pathogenic Streptococcus agalactiae.

Authors:  Javier Fernando Melo-Bolívar; Ruth Yolanda Ruiz Pardo; Michael E Hume; David J Nisbet; Fernando Rodríguez-Villamizar; Juan F Alzate; Howard Junca; Luisa Marcela Villamil Díaz
Journal:  PLoS One       Date:  2019-05-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.